Quantifying NSAID Abuse
NSAID abuse should be quantified using DSM-5 substance use disorder criteria, combined with specific behavioral markers: taking ≥2 NSAIDs concurrently for ≥3 days, exceeding maximum recommended daily dosages, or meeting ≥2 DSM-5 criteria for substance use disorder. 1
Operational Definition of NSAID Abuse
The most clinically actionable approach combines two validated methods:
Behavioral Quantification
- Concurrent use: Taking 2 or more different NSAIDs simultaneously for 3 or more days 2
- Dose escalation: Exceeding manufacturer's maximum recommended daily dosage for any single NSAID 2
- Prevalence data: Approximately 32% of regular NSAID users engage in inappropriate use, with 19% exceeding recommended doses and 24% using multiple NSAIDs concomitantly 3, 2
DSM-5 Diagnostic Framework
The Mini International Neuropsychiatric Interview (MINI) can successfully apply DSM-5 substance use disorder criteria to NSAIDs 1. Look for:
- Continued use despite knowledge of physical/psychological harm
- Tolerance (needing increased amounts)
- Failed attempts to cut down
- Time spent obtaining/using NSAIDs
- Social/occupational impairment
- Use in physically hazardous situations
Severity grading: Mild (2-3 criteria), Moderate (4-5 criteria), Severe (≥6 criteria) 1
High-Risk Populations to Screen
Target your assessment toward:
- Athletes and sports participants (higher rates of non-medical use) 4
- Minorities and low-income patients (odds ratio 1.62 and 1.70 respectively for inappropriate use) 2
- Patients with chronic pain (β = 0.85 correlation with inappropriate use) 2
- Those with GI symptoms (β = 0.57 correlation, suggesting continued use despite harm) 2
- Elderly patients (34% take NSAIDs daily, 70% weekly) 5
Critical Pitfalls in Assessment
Poor NSAID recognition: Most patients cannot identify NSAIDs by generic or brand names, leading to unintentional multi-drug use 3. Specifically ask about:
- All prescription pain medications
- Over-the-counter products (ibuprofen, naproxen, aspirin)
- Combination products containing NSAIDs
- Topical NSAID formulations
Lack of awareness: Many patients are unconcerned about NSAID side effects and don't recognize them as "real drugs" that can cause harm 3. This pattern has remained unchanged since 2002 despite increased usage 3.
Quantifiable Thresholds for Intervention
Document these specific parameters:
- Daily dose vs. maximum recommended (varies by agent)
- Number of different NSAIDs used concurrently
- Duration of continuous use (cardiovascular risk increases with duration) 6
- Frequency of use (daily vs. intermittent)
- Total weekly/monthly consumption
The economic burden provides additional context: for every dollar spent on NSAIDs, $0.66-$1.25 is spent managing GI complications, with 31% of arthritis management costs addressing NSAID adverse events 5.